NEW YORK, Sept. 17, 2014 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Retrophin, Inc. ("Retrophin" or the "Company") (NasdaqGM:RTRX -News). Such investors are advised to contact Peretz Bronstein or his investor relations coordinator Eitan Kimelman at info@bgandg.com or 212-697-6484.
The investigation focuses on whether the Company and certain of its executives violated federal securities laws.